539 related articles for article (PubMed ID: 8052651)
1. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.
Nishikawa R; Ji XD; Harmon RC; Lazar CS; Gill GN; Cavenee WK; Huang HJ
Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7727-31. PubMed ID: 8052651
[TBL] [Abstract][Full Text] [Related]
2. The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling.
Huang HS; Nagane M; Klingbeil CK; Lin H; Nishikawa R; Ji XD; Huang CM; Gill GN; Wiley HS; Cavenee WK
J Biol Chem; 1997 Jan; 272(5):2927-35. PubMed ID: 9006938
[TBL] [Abstract][Full Text] [Related]
3. The protein tyrosine phosphatase TCPTP suppresses the tumorigenicity of glioblastoma cells expressing a mutant epidermal growth factor receptor.
Klingler-Hoffmann M; Fodero-Tavoletti MT; Mishima K; Narita Y; Cavenee WK; Furnari FB; Huang HJ; Tiganis T
J Biol Chem; 2001 Dec; 276(49):46313-8. PubMed ID: 11514572
[TBL] [Abstract][Full Text] [Related]
4. Human glioblastoma xenografts overexpressing a tumor-specific mutant epidermal growth factor receptor sensitized to cisplatin by the AG1478 tyrosine kinase inhibitor.
Nagane M; Narita Y; Mishima K; Levitzki A; Burgess AW; Cavenee WK; Huang HJ
J Neurosurg; 2001 Sep; 95(3):472-9. PubMed ID: 11565870
[TBL] [Abstract][Full Text] [Related]
5. Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas.
Yadav AK; Renfrow JJ; Scholtens DM; Xie H; Duran GE; Bredel C; Vogel H; Chandler JP; Chakravarti A; Robe PA; Das S; Scheck AC; Kessler JA; Soares MB; Sikic BI; Harsh GR; Bredel M
JAMA; 2009 Jul; 302(3):276-89. PubMed ID: 19602687
[TBL] [Abstract][Full Text] [Related]
6. Glioblastoma stem-like cell lines with either maintenance or loss of high-level EGFR amplification, generated via modulation of ligand concentration.
Schulte A; Günther HS; Martens T; Zapf S; Riethdorf S; Wülfing C; Stoupiec M; Westphal M; Lamszus K
Clin Cancer Res; 2012 Apr; 18(7):1901-13. PubMed ID: 22316604
[TBL] [Abstract][Full Text] [Related]
7. Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells.
Ramnarain DB; Park S; Lee DY; Hatanpaa KJ; Scoggin SO; Otu H; Libermann TA; Raisanen JM; Ashfaq R; Wong ET; Wu J; Elliott R; Habib AA
Cancer Res; 2006 Jan; 66(2):867-74. PubMed ID: 16424019
[TBL] [Abstract][Full Text] [Related]
8. Glioblastoma-related gene mutations and over-expression of functional epidermal growth factor receptors in SKMG-3 glioma cells.
Thomas C; Ely G; James CD; Jenkins R; Kastan M; Jedlicka A; Burger P; Wharen R
Acta Neuropathol; 2001 Jun; 101(6):605-15. PubMed ID: 11515790
[TBL] [Abstract][Full Text] [Related]
9. Reverse transcriptase polymerase chain reaction as a reliable method to detect epidermal growth factor receptor exon 2-7 gene deletion in human glioblastomas.
Worm K; Dabbagh P; Schwechheimer K
Hum Pathol; 1999 Feb; 30(2):222-7. PubMed ID: 10029453
[TBL] [Abstract][Full Text] [Related]
10. Specific targeting of a mutant, activated FGF receptor found in glioblastoma using a monoclonal antibody.
Hills D; Rowlinson-Busza G; Gullick WJ
Int J Cancer; 1995 Nov; 63(4):537-43. PubMed ID: 7591264
[TBL] [Abstract][Full Text] [Related]
11. EGFR gene amplification--rearrangement in human glioblastomas.
Schwechheimer K; Huang S; Cavenee WK
Int J Cancer; 1995 Jul; 62(2):145-8. PubMed ID: 7622287
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody against the fusion junction of a deletion-mutant epidermal growth factor receptor.
Okamoto S; Yoshikawa K; Obata Y; Shibuya M; Aoki S; Yoshida J; Takahashi T
Br J Cancer; 1996 Jun; 73(11):1366-72. PubMed ID: 8645581
[TBL] [Abstract][Full Text] [Related]
13. The hydroxyurea-induced loss of double-minute chromosomes containing amplified epidermal growth factor receptor genes reduces the tumorigenicity and growth of human glioblastoma multiforme.
Canute GW; Longo SL; Longo JA; Shetler MM; Coyle TE; Winfield JA; Hahn PJ
Neurosurgery; 1998 Mar; 42(3):609-16. PubMed ID: 9526995
[TBL] [Abstract][Full Text] [Related]
14. Marked inhibition of glioblastoma target cell tumorigenicity in vitro by retrovirus-mediated transfer of a hairpin ribozyme against deletion-mutant epidermal growth factor receptor messenger RNA.
Halatsch ME; Schmidt U; Bötefür IC; Holland JF; Ohnuma T
J Neurosurg; 2000 Feb; 92(2):297-305. PubMed ID: 10659018
[TBL] [Abstract][Full Text] [Related]
15. Depatuxizumab Mafodotin (ABT-414)-induced Glioblastoma Cell Death Requires EGFR Overexpression, but not EGFR
von Achenbach C; Silginer M; Blot V; Weiss WA; Weller M
Mol Cancer Ther; 2020 Jun; 19(6):1328-1339. PubMed ID: 32371586
[TBL] [Abstract][Full Text] [Related]
16. A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis.
Nagane M; Coufal F; Lin H; Bögler O; Cavenee WK; Huang HJ
Cancer Res; 1996 Nov; 56(21):5079-86. PubMed ID: 8895767
[TBL] [Abstract][Full Text] [Related]
17. Acquired rearrangement of an amplified epidermal growth factor receptor (EGFR) gene in a human glioblastoma xenograft.
Goike HM; Asplund AC; Pettersson EH; Liu L; Sanoudou D; Collins VP
J Neuropathol Exp Neurol; 1999 Jul; 58(7):697-701. PubMed ID: 10411339
[TBL] [Abstract][Full Text] [Related]
18. Deletion-mutant epidermal growth factor receptor in human gliomas: effects of type II mutation on receptor function.
Humphrey PA; Gangarosa LM; Wong AJ; Archer GE; Lund-Johansen M; Bjerkvig R; Laerum OD; Friedman HS; Bigner DD
Biochem Biophys Res Commun; 1991 Aug; 178(3):1413-20. PubMed ID: 1678600
[TBL] [Abstract][Full Text] [Related]
19. A deletion mutation within the ligand binding domain is responsible for activation of epidermal growth factor receptor gene in human brain tumors.
Yamazaki H; Ohba Y; Tamaoki N; Shibuya M
Jpn J Cancer Res; 1990 Aug; 81(8):773-9. PubMed ID: 2168866
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel fusion gene HMGA2-EGFR in glioblastoma.
Komuro A; Raja E; Iwata C; Soda M; Isogaya K; Yuki K; Ino Y; Morikawa M; Todo T; Aburatani H; Suzuki H; Ranjit M; Natsume A; Mukasa A; Saito N; Okada H; Mano H; Miyazono K; Koinuma D
Int J Cancer; 2018 Apr; 142(8):1627-1639. PubMed ID: 29193056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]